Skip to main content

Table 2 Complications

From: Transobturator suburethral tapes in the management of urinary incontinence: success, safety and impact on sexual life

 

Total TOTs

Obtape

TVT-O

Fischer exact test

n = 276 (%)

n = 182 (%)

n = 94 (%)

Intraoperative

  Bladder injury

1 (0.4%)

1 (0.6%)

0

p = 1

  Urethral injury

2 (0.7%)

2 (1.1%)

0

p = 0.55

  Blood loss >200 ml

15 (5.4%)

9 (5%)

6 (6.4%)

p = 0.59

  Lateral vaginal wall tears

12 (4.3%)

11 (6%)

1 (1%)

p = 0.06

    

Chi-square = 1.723

Total

30 (10.8%)

23

7

p = 0.2

Early postoperative

  Perineal cellulites

1 (0.4%)

1 (0.6%)

0

p = 1

  Urinary tract infection

14 (5.1%)

8 (4.4%)

6 (6.4%)

p = 0.56

  Complete urinary retention

1 (0.4%)

1 (0.6%)

0

p = 1

  Voiding difficulties: 24 h–1 week

15 (5.4%)

9 (5%)

6 (6.4%)

p = 0.59

  Voiding difficulties: more than 1 week

7 (2.5%)

5 (2.7%)

2 (2.1%)

p = 1

  Surgical tape release

4 (1.5%)

3 (1.6%)

1 (1%)

p = 1

  CISC

3 (1.1%)

2 (1.1%)

1 (1%)

p = 1

  Pain necessitating readmission

1

0

1 (1%)

p = 1

    

Chi-square = 0.21

Total

46 (16.7%)

29

17

p=0.65

Late postoperative

  Vaginal mesh erosion

14 (5.1%)

12 (6.6%)

2 (2.1%)

p = 0.15

  De novo urge symptoms

19 (6.9 %)

14 (7.7%)

5 (5.3%)

p = 0.6

  Ischiorectal abscess

3 (1.1%)

3 (1.6%)

0

p = 0.55

    

Chi-square = 3.94

Total

36 (13.1%)

29

7

p < 0.047*

  1. TOT transobturator tension-free vaginal tape, CISC clean intermittent self-catheterization
  2. P is significant at 0.05
  3. * Statistically significant difference